Exhibiting, Advertising and Hosting Opportunities Now Available

Request Further Information

Innovative Therapies, including cell and gene and ATMPs, are becoming one of the main focus areas for the industry. Developing those very complex therapies fast, authorizing, making them accessible, delivering and ensuring safety for patients throughout the life cycle of these products are the main challenges in this field. On the road towards solutions, join the collaborative efforts of key stakeholders and experts in the area of market access from industry, HTA bodies, payers, regulators and academia in the fourth edition of the DIA-EUCOPE Workshop focusing on lessons learned and applications for the new entrants. In the series of plenary and break-out sessions, we will share specific case studies review gained experience, and discuss approaches that can be taken to improve market access of these therapies.

With over 90 attendees from over 15 countries, don’t miss your chance to connect with the decision makers and showcase your products and solutions to the right people!

CONNECT WITH...

• Research and Development, Regulatory and Access Professionals from Organisations developing Cell and Gene therapies, impacted by the related regulations and policies.
• Regulators, payers and patients who are impacted by or participating in the decisions or policies related to Cell and Gene therapies

….and many more!

You will be able to enjoy the valuable insights that your chosen conference will have to offer.